NEW YORK – Troutman Pepper advised Absorption Systems, a leading scientific, non-clinical CRO (contract research organization), in its sale to Pharmaron Beijing Co., Limited, a fully integrated contract research and manufacturing organization. Read a company press release about the transaction.

Absorption Systems provides pharmaceutical, biotech, medical device companies and regulatory agencies with research and testing for small and large molecules, cell and gene therapies, ocular and medical device products. Troutman Pepper’s Todd Boylan and William Scari advised Absorption Systems in the deal.

Health sciences is a core practice at Troutman Pepper. The firm has more than 150 attorneys who represent clients such as innovative biotech, pharmaceutical and medical device developers and manufacturers; physicians, hospitals and other health care providers; health insurers and other payors; and a wide range of members of the health care supply chain.

About Troutman Pepper 
Troutman Pepper is a national law firm known for its higher commitment to client care. With more than 1,100 attorneys in 23 U.S. cities, the firm partners with clients across every industry sector to help them achieve their business goals. Read more about the firm’s litigation, transactional, and regulatory practices at troutman.com.

Insight Industries + Practices